Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management raised its holdings in shares of Mylan N.V. (NASDAQ:MYL) by 6.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,311,700 shares of the company’s stock after acquiring an additional 138,500 shares during the quarter. Mylan N.V. makes up 4.6% of Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management’s portfolio, making the stock its 3rd largest holding. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management owned 0.43% of Mylan N.V. worth $72,518,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the company. Bellwether Investment Group LLC lifted its stake in shares of Mylan N.V. by 0.3% during the 2nd quarter. Bellwether Investment Group LLC now owns 6,622 shares of the company’s stock valued at $257,000 after buying an additional 23 shares in the last quarter. Suntrust Banks Inc. lifted its stake in shares of Mylan N.V. by 0.7% during the 2nd quarter. Suntrust Banks Inc. now owns 9,184 shares of the company’s stock valued at $355,000 after buying an additional 60 shares in the last quarter. Dai Ichi Life Insurance Company Ltd lifted its stake in shares of Mylan N.V. by 0.4% during the 2nd quarter. Dai Ichi Life Insurance Company Ltd now owns 26,002 shares of the company’s stock valued at $1,009,000 after buying an additional 107 shares in the last quarter. Wealthsource Partners LLC lifted its stake in Mylan N.V. by 1.9% in the 2nd quarter. Wealthsource Partners LLC now owns 9,330 shares of the company’s stock worth $362,000 after purchasing an additional 177 shares in the last quarter. Finally, Bank of Nova Scotia lifted its stake in Mylan N.V. by 1.9% in the 1st quarter. Bank of Nova Scotia now owns 10,525 shares of the company’s stock worth $410,000 after purchasing an additional 196 shares in the last quarter. Institutional investors and hedge funds own 72.01% of the company’s stock.

Shares of Mylan N.V. (MYL) traded up $0.32 during mid-day trading on Monday, reaching $36.04. 1,385,469 shares of the company’s stock were exchanged, compared to its average volume of 5,217,081. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.35 and a quick ratio of 0.84. The company has a market cap of $19,155.95, a P/E ratio of 7.17, a P/E/G ratio of 1.93 and a beta of 1.38. Mylan N.V. has a twelve month low of $29.39 and a twelve month high of $45.87.

Mylan N.V. (NASDAQ:MYL) last announced its quarterly earnings results on Monday, November 6th. The company reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.20 by ($0.10). Mylan N.V. had a return on equity of 22.42% and a net margin of 5.51%. The business had revenue of $2.99 billion during the quarter, compared to analysts’ expectations of $3.09 billion. During the same period in the previous year, the company posted $1.38 EPS. Mylan N.V.’s revenue for the quarter was down 2.3% on a year-over-year basis. analysts expect that Mylan N.V. will post 4.63 earnings per share for the current fiscal year.

Several brokerages have commented on MYL. Citigroup Inc. upgraded shares of Mylan N.V. from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $36.00 to $42.00 in a research note on Wednesday, August 16th. Royal Bank Of Canada reiterated a “sector perform” rating and issued a $32.00 price target (down previously from $33.00) on shares of Mylan N.V. in a research note on Thursday, August 10th. Cowen and Company restated a “hold” rating and issued a $30.00 target price (down from $43.00) on shares of Mylan N.V. in a report on Wednesday, August 9th. Wells Fargo & Company set a $32.00 target price on shares of Mylan N.V. and gave the stock a “hold” rating in a report on Wednesday, October 4th. Finally, Cantor Fitzgerald set a $34.00 target price on shares of Mylan N.V. and gave the stock a “hold” rating in a report on Wednesday, August 9th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and thirteen have assigned a buy rating to the company’s stock. Mylan N.V. has an average rating of “Buy” and a consensus target price of $41.21.

WARNING: This article was originally reported by Watch List News and is the property of of Watch List News. If you are viewing this article on another site, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The legal version of this article can be read at https://www.watchlistnews.com/mivtachim-the-workers-social-insurance-fund-ltd-under-special-management-acquires-138500-shares-of-mylan-n-v-myl/1682829.html.

Mylan N.V. Profile

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Institutional Ownership by Quarter for Mylan N.V. (NASDAQ:MYL)

Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.